IOF vs. SYNT, TET, ZTF, WCH, ITX, DCTA, HAYD, HDD, BIOM, and VRS
Should you be buying Iofina stock or one of its competitors? The main competitors of Iofina include Synthomer (SYNT), Treatt (TET), Zotefoams (ZTF), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Directa Plus (DCTA), Haydale Graphene Industries (HAYD), Hardide (HDD), Biome Technologies (BIOM), and Versarien (VRS). These companies are all part of the "specialty chemicals" industry.
Iofina vs. Its Competitors
Iofina (LON:IOF) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, community ranking, media sentiment, analyst recommendations, profitability and dividends.
Synthomer received 531 more outperform votes than Iofina when rated by MarketBeat users. Likewise, 68.46% of users gave Synthomer an outperform vote while only 66.44% of users gave Iofina an outperform vote.
6.4% of Iofina shares are owned by institutional investors. Comparatively, 43.8% of Synthomer shares are owned by institutional investors. 45.1% of Iofina shares are owned by company insiders. Comparatively, 28.0% of Synthomer shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Iofina has a net margin of 6.98% compared to Synthomer's net margin of -4.40%. Iofina's return on equity of 8.00% beat Synthomer's return on equity.
Iofina presently has a consensus target price of GBX 36.25, suggesting a potential upside of 47.66%. Synthomer has a consensus target price of GBX 225, suggesting a potential upside of 95.60%. Given Synthomer's higher possible upside, analysts plainly believe Synthomer is more favorable than Iofina.
Iofina has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500. Comparatively, Synthomer has a beta of 1.79, meaning that its share price is 79% more volatile than the S&P 500.
In the previous week, Synthomer had 1 more articles in the media than Iofina. MarketBeat recorded 2 mentions for Synthomer and 1 mentions for Iofina. Iofina's average media sentiment score of 1.20 beat Synthomer's score of -0.10 indicating that Iofina is being referred to more favorably in the media.
Iofina has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.
Summary
Iofina beats Synthomer on 11 of the 18 factors compared between the two stocks.
Get Iofina News Delivered to You Automatically
Sign up to receive the latest news and ratings for IOF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding IOF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools
This page (LON:IOF) was last updated on 6/13/2025 by MarketBeat.com Staff